Global NSAIDs Market Insights, Forecast to 2025


The global NSAIDs market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the NSAIDs market based on company, product type, end user and key regions.

This report studies the global market size of NSAIDs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of NSAIDs in these regions.
This research report categorizes the global NSAIDs market by top players/brands, region, type and end user. This report also studies the global NSAIDs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson & Johnson
Geri-Care Pharmaceuticals
Perrigo Company
Merck Sharp & Dohme
Sun Pharmaceutical Industries
Reddy Pharmaceuticals

Market size by Product
Market size by End User
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment

Market size by Region
North America
United States
South Korea
Central & South America
Rest of Central & South America
Middle East & Africa
GCC Countries
South Africa

The study objectives of this report are:
To study and analyze the global NSAIDs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of NSAIDs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global NSAIDs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of NSAIDs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of NSAIDs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of NSAIDs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

1 Study Coverage
1.1 NSAIDs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global NSAIDs Market Size Growth Rate by Product
1.4.2 Aspirin
1.4.3 Ibuprofen
1.4.4 Naproxen
1.4.5 Nabumetone
1.4.6 Others
1.5 Market by End User
1.5.1 Global NSAIDs Market Size Growth Rate by End User
1.5.2 Back Pain Treatment
1.5.3 Osteoarthritis Treatment
1.5.4 Other Disease Treatment
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global NSAIDs Market Size
2.1.1 Global NSAIDs Revenue 2014-2025
2.1.2 Global NSAIDs Sales 2014-2025
2.2 NSAIDs Growth Rate by Regions
2.2.1 Global NSAIDs Sales by Regions
2.2.2 Global NSAIDs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 NSAIDs Sales by Manufacturers
3.1.1 NSAIDs Sales by Manufacturers
3.1.2 NSAIDs Sales Market Share by Manufacturers
3.1.3 Global NSAIDs Market Concentration Ratio (CR5 and HHI)
3.2 NSAIDs Revenue by Manufacturers
3.2.1 NSAIDs Revenue by Manufacturers (2014-2019)
3.2.2 NSAIDs Revenue Share by Manufacturers (2014-2019)
3.3 NSAIDs Price by Manufacturers
3.4 NSAIDs Manufacturing Base Distribution, Product Types
3.4.1 NSAIDs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers NSAIDs Product Type
3.4.3 Date of International Manufacturers Enter into NSAIDs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global NSAIDs Sales by Product
4.2 Global NSAIDs Revenue by Product
4.3 NSAIDs Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global NSAIDs Breakdown Data by End User

6 North America
6.1 North America NSAIDs by Countries
6.1.1 North America NSAIDs Sales by Countries
6.1.2 North America NSAIDs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America NSAIDs by Product
6.3 North America NSAIDs by End User

7 Europe
7.1 Europe NSAIDs by Countries
7.1.1 Europe NSAIDs Sales by Countries
7.1.2 Europe NSAIDs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe NSAIDs by Product
7.3 Europe NSAIDs by End User

8 Asia Pacific
8.1 Asia Pacific NSAIDs by Countries
8.1.1 Asia Pacific NSAIDs Sales by Countries
8.1.2 Asia Pacific NSAIDs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific NSAIDs by Product
8.3 Asia Pacific NSAIDs by End User

9 Central & South America
9.1 Central & South America NSAIDs by Countries
9.1.1 Central & South America NSAIDs Sales by Countries
9.1.2 Central & South America NSAIDs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America NSAIDs by Product
9.3 Central & South America NSAIDs by End User

10 Middle East and Africa
10.1 Middle East and Africa NSAIDs by Countries
10.1.1 Middle East and Africa NSAIDs Sales by Countries
10.1.2 Middle East and Africa NSAIDs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa NSAIDs by Product
10.3 Middle East and Africa NSAIDs by End User

11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Company Business Overview
11.1.3 Bayer NSAIDs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bayer NSAIDs Products Offered
11.1.5 Bayer Recent Development
11.2 Novacap
11.2.1 Novacap Company Details
11.2.2 Company Business Overview
11.2.3 Novacap NSAIDs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novacap NSAIDs Products Offered
11.2.5 Novacap Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Company Business Overview
11.3.3 Abbott NSAIDs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Abbott NSAIDs Products Offered
11.3.5 Abbott Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer NSAIDs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer NSAIDs Products Offered
11.4.5 Pfizer Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Company Business Overview
11.5.3 Johnson & Johnson NSAIDs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Johnson & Johnson NSAIDs Products Offered
11.5.5 Johnson & Johnson Recent Development
11.6 Cigna
11.6.1 Cigna Company Details
11.6.2 Company Business Overview
11.6.3 Cigna NSAIDs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Cigna NSAIDs Products Offered
11.6.5 Cigna Recent Development
11.7 Geri-Care Pharmaceuticals
11.7.1 Geri-Care Pharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Geri-Care Pharmaceuticals NSAIDs Products Offered
11.7.5 Geri-Care Pharmaceuticals Recent Development
11.8 Perrigo Company
11.8.1 Perrigo Company Company Details
11.8.2 Company Business Overview
11.8.3 Perrigo Company NSAIDs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Perrigo Company NSAIDs Products Offered
11.8.5 Perrigo Company Recent Development
11.9 Kopran
11.9.1 Kopran Company Details
11.9.2 Company Business Overview
11.9.3 Kopran NSAIDs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Kopran NSAIDs Products Offered
11.9.5 Kopran Recent Development
11.10 Merck Sharp & Dohme
11.10.1 Merck Sharp & Dohme Company Details
11.10.2 Company Business Overview
11.10.3 Merck Sharp & Dohme NSAIDs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Merck Sharp & Dohme NSAIDs Products Offered
11.10.5 Merck Sharp & Dohme Recent Development
11.11 Sun Pharmaceutical Industries
11.12 GlaxoSmithKline
11.13 Reddy Pharmaceuticals
11.14 Verywell

12 Future Forecast
12.1 NSAIDs Market Forecast by Regions
12.1.1 Global NSAIDs Sales Forecast by Regions 2019-2025
12.1.2 Global NSAIDs Revenue Forecast by Regions 2019-2025
12.2 NSAIDs Market Forecast by Product
12.2.1 Global NSAIDs Sales Forecast by Product 2019-2025
12.2.2 Global NSAIDs Revenue Forecast by Product 2019-2025
12.3 NSAIDs Market Forecast by End User
12.4 North America NSAIDs Forecast
12.5 Europe NSAIDs Forecast
12.6 Asia Pacific NSAIDs Forecast
12.7 Central & South America NSAIDs Forecast
12.8 Middle East and Africa NSAIDs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 NSAIDs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Choose License Type

Checkout Inquiry Sample